Clement Ngai primarily handles general IP advice, as well as enforcement and anti-piracy programs in Asia. Prior to joining the Firm, Mr. Ngai was the chief IP counsel in Asia for a multinational corporation with significant presence in China and was responsible for all IP matters in the region. He also served as chairman for the Business Software Alliance China Committee from 2000-2006. In this role, he represented the interests of the US software industry in lobbying the Chinese government for the better protection of software IP rights. He was also in charge of the anti-piracy program in China.
Mr. Ngai’s has extensive IP enforcement experience in many jurisdictions in Asia (Hong Kong, Taiwan, Korea, China, Singapore and India), running anti-piracy programs for the software industry in those countries. He also advises on general IP-related matters, software copyright issues, computer and IT matters, patent strategy, R&D IP issues, IP security, and government lobbying on IP laws. One of his main focuses in on China, where he spends most of his time.
Representative Legal Matters
- Chairman of Business Software Alliance, China Committee 2000-2006
- Chairman of Business Software Alliance, Korea Committee 2002-2003
- Chairman of Business Software Alliance, India Committee 2004-2005
- Leading the anti-piracy programs for Business Software Alliance member companies in China (2000-2006), Hong Kong (1999-2001), Taiwan (1999-2001), Korea (2002-2003), India (2004-2005)
- Extensive experiences IP litigations in China.
- Reviewing and advising European pharmaceutical and US biotech companies on clinical trial agreements in China.
- Conducting regulatory review for US multinational dental healthcare company on its new advertising and promotional campaign in China and Hong Kong.
- Speaking at the BioMed Asia Conference on Pharmaceutical Outsourcing issues in China
- Advising US Biotech equipment manufacturer on IP strategy in its R&D centre in Shanghai
- Advising on R&D IP matters and invention disclosures in China.
- Advising US Biotech company on joint development and pharmaceutical outsourcing issues in China.
- Conducting and co-ordinating review of inventions or other patentable innovations.
- Co-ordinating technology and product clearance (freedom to operate) process in China.
- Leading an in-house anti-counterfeiting campaign for US multinational in China and against Chinese origin goods overseas.
- Liaison and lobby Chinese government officials (National Copyright Administration, Ministry of Information Industry, State Intellectual Property Office, Supreme People’s Court, Legislative Affair Office of the State Council, Ministry of Finance) on IP matters including lobbying for legislative changes; regular dialogue and provide feedback to US agencies involved in IP issues (e.g. US Embassy, USTR, Foreign Commercial Services, US Patent and Trademark Office etc).
Hong Kong (1997)
The University of Hong Kong (P.C.LL.) (1994)
University of London (LL.B.) (1993)
Chinese University of Hong Kong (Master's Degree Philosophy) (1992)
The University of Hong Kong (B.Sc.) (1989)